Aggregated China Business Blogs



Biotech Week in Review: East-West Pharma Interaction

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
December 23, 2007|

Beijing Mefuvir Medicinal Technology in-licensed from Medivir of Sweden the Asian rights (ex-Japan) to an HIV nucleoside reverse transcriptase inhibitor that has already completed Phase II tests.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • China Biotech Week in Review: East-West Pharma Interaction
  • Biotech Week in Review: Cross Border China Pharma Activity
  • China Biotech Week in Review: East-West Interdependence in 2007
  • Earnings and More in China Biotech Weekly Review
  • China Biotech in Review: A Week of Collaborations

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |